| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/18/2004 | EP1294732B1 Ruthenium (ii) compounds for use in the therapy of cancer |
| 08/18/2004 | EP1294366B1 Pharmaceutical compounds for treating copd |
| 08/18/2004 | EP1286997B1 6-phenylpyrrolopyrimidinedione derivatives |
| 08/18/2004 | EP1268429B1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/18/2004 | EP1257552B1 Xanthine derivatives, intermediates and use for treating osteoporosis |
| 08/18/2004 | EP1252170B1 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 08/18/2004 | EP1228079B1 Novel fucosylated oligosaccharides and process for their preparation |
| 08/18/2004 | EP1212309B1 Caspase inhibitor |
| 08/18/2004 | EP1202713B1 Artificial tear replacement solution |
| 08/18/2004 | EP1194426B1 Benzofurane derivatives |
| 08/18/2004 | EP1194109B1 Topical formulations comprising skin penetration agents and the use thereof |
| 08/18/2004 | EP1189924B1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 08/18/2004 | EP1187814B1 5-phenyl-pyrimidine derivatives |
| 08/18/2004 | EP1187611B1 Ophthalmic histamine compositions and uses thereof |
| 08/18/2004 | EP1179343B1 Remedies for diabetes comprising 2-(n-cyanoimino)thiazolidine-4-one derivatives |
| 08/18/2004 | EP1178833B1 Topical compositions for prostaglandin e 1 delivery |
| 08/18/2004 | EP1175397B1 3,3-substituted indoline derivatives |
| 08/18/2004 | EP1144361B1 Method for reducing 3-dimethylamino-2-phenylpropion-acid ethyl ester-content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester |
| 08/18/2004 | EP1140119B1 Use OF LOW MOLECULAR WEIGHT HEPARIN for the prevention and/or treatment of motoneuronal diseases |
| 08/18/2004 | EP1139789B1 Alpha-amylase-resistant starch for producing foodstuff and medicaments |
| 08/18/2004 | EP1134220B1 Benzoxazole derivatives and drugs containing the same as the active ingredient |
| 08/18/2004 | EP1117676B1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 08/18/2004 | EP1117390B1 Mucosal originated drug delivery systems |
| 08/18/2004 | EP1094841B1 Pharmaceutical levothyroxine preparation |
| 08/18/2004 | EP1087935B1 Anthracene derivatives as anti-cancer agents |
| 08/18/2004 | EP1086082B1 Arylsubstituted olefinic amines and their use as cholinergic receptors agonists |
| 08/18/2004 | EP1037636A4 Inhibition of membrane-associated viral replication |
| 08/18/2004 | EP1030857B1 Adenosine a1 receptor agonists |
| 08/18/2004 | EP1030856B1 Adenosine a1 receptor agonists |
| 08/18/2004 | EP1012188B1 Composition for treating diabetes mellitus and obesity |
| 08/18/2004 | EP1011610A4 Skin care compositions and use |
| 08/18/2004 | EP1004296B1 Powder containing fat-soluble drug |
| 08/18/2004 | EP0989957B1 Improved method for preparing low-concentration polyaluminosilicate microgels |
| 08/18/2004 | EP0984928A4 Aromatic and heterocyclic nitrato derivatives |
| 08/18/2004 | EP0954330A4 Intestinal trefoil proteins |
| 08/18/2004 | EP0944599B1 Triarylethanes useful as pde iv inhibitors |
| 08/18/2004 | EP0909171B1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 08/18/2004 | EP0885006B1 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin |
| 08/18/2004 | EP0881914B1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/18/2004 | EP0881899B1 Dosage form of ibuprofen |
| 08/18/2004 | EP0876345B1 Heterocyclic compounds as h+-atpases |
| 08/18/2004 | EP0876166B1 Use of injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
| 08/18/2004 | EP0871730B1 Combination pdgf, kgf, igf and igfbp for wound healing |
| 08/18/2004 | EP0862622B1 Method of screening for RAC protein kinase interacting compounds |
| 08/18/2004 | EP0833627B1 Iron compounds, compositions, methods of making the same and uses thereof |
| 08/18/2004 | EP0744950B1 Agent for prophylaxis and treatment of thromboxane a2 mediated diseases |
| 08/18/2004 | EP0706387B1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 08/18/2004 | CN1522303A Method for detecting a risk of hypertension and uses thereof |
| 08/18/2004 | CN1522301A Process for producing fat comprising triglyceride containing highly unsaturated fatty acid |
| 08/18/2004 | CN1522263A Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
| 08/18/2004 | CN1522259A Cephem compounds |
| 08/18/2004 | CN1522258A Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 08/18/2004 | CN1522257A Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 08/18/2004 | CN1522256A Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 08/18/2004 | CN1522254A Immunomodulating compounds |
| 08/18/2004 | CN1522252A Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/18/2004 | CN1522249A Quinoline derivatives as ligands for the neuropeptide y receptor |
| 08/18/2004 | CN1522246A Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein b (APO B) secretion |
| 08/18/2004 | CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 08/18/2004 | CN1522244A Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/18/2004 | CN1522241A Crystalline form of a phenylethanolamine, preparation thereof and pharmaceutical compositions comprising same |
| 08/18/2004 | CN1522160A Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 08/18/2004 | CN1522158A Treatment of parasitic disease |
| 08/18/2004 | CN1522157A Optic nerve protecting agents containing alpha1 receptor blocker as the active ingredient |
| 08/18/2004 | CN1522149A Promoting whole body health |
| 08/18/2004 | CN1522148A Facially amphiphilic polymers as anti-infective agents |
| 08/18/2004 | CN1522147A Composition for treating drug-induced constipation with 15-keto-prostaglandins |
| 08/18/2004 | CN1522146A Use of cyclopamine in the treatment of psoriasis |
| 08/18/2004 | CN1522145A Compositions and methods for treating vulvovaginitis and vaginosis |
| 08/18/2004 | CN1522144A Compositions for preventing human cancer and method of preventing human cancer |
| 08/18/2004 | CN1522143A Coenzyme q and eicosapentaenoic acid (epa) |
| 08/18/2004 | CN1522142A Potassium channel opener |
| 08/18/2004 | CN1522141A Soft capsules |
| 08/18/2004 | CN1522140A Oxcarbazepine dosage forms |
| 08/18/2004 | CN1522139A Enhanced parmacokinetic profile of hydrophobic substances |
| 08/18/2004 | CN1522135A Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 08/18/2004 | CN1522132A Composition for freshening nostrils and sinus cavities |
| 08/18/2004 | CN1521258A Novel epothilones compound and its preparation method and application |
| 08/18/2004 | CN1521193A Chickweed polysaccharide , their production method , use ,combination and preparation |
| 08/18/2004 | CN1521179A Chickweed total flavones , their production method , use and preparation containing the same |
| 08/18/2004 | CN1521175A Bitter leaf naphthalene extract and its use |
| 08/18/2004 | CN1521171A Boric acid and boric acid ester compound ,their preparing method and use in pharmacy |
| 08/18/2004 | CN1521157A Protein tyrosine phosphatase 1B inhibitor para-benzoquinone compound and process for preparing the same |
| 08/18/2004 | CN1520879A Chinese caterpillar fungus ginseng dan drop pills and preparing process thereof |
| 08/18/2004 | CN1520853A Sonchifolia Hance solid medical preparation and its manufacture process |
| 08/18/2004 | CN1520852A Sonchifolia Hance oral liquid and its manufacture process |
| 08/18/2004 | CN1520844A Traditional Chinese medicine composition for cancer |
| 08/18/2004 | CN1520836A Pharmaceutical composition for treating hepatitis |
| 08/18/2004 | CN1520826A Medicinal composition for improving sea-buckthorn flavone bioavailability |
| 08/18/2004 | CN1520825A Use of New Zealand vitexin-1 in preparation of antiviral drug |
| 08/18/2004 | CN1520824A Pharmaceutical use of asiaticoside |
| 08/18/2004 | CN1520823A Novel compound antineoplastic drug preparing process |
| 08/18/2004 | CN1520822A Novel compound antimalarial preparation method |
| 08/18/2004 | CN1520821A Cefonicid sodium antibacterial composition |
| 08/18/2004 | CN1520820A Slow release levodropropizine pharmaceutical composition |
| 08/18/2004 | CN1520819A Substituted morphinan and uses of its pharmaceutically acceptable salt |
| 08/18/2004 | CN1520818A Cholinesterase inhibitor pharmaceutical composition for senile dementia |
| 08/18/2004 | CN1520817A Nimodipine slow release capsule and its preparation method |
| 08/18/2004 | CN1520816A Sophocarpidine gel preparation and its process |
| 08/18/2004 | CN1520815A Flavescent sophora root drop pills for treating hepatitis B |